Feature Channels: Personalized Medicine

Filters close
Released: 25-Mar-2024 12:35 PM EDT
Nucleus Genomics launches to bring whole-genome sequencing to the public
Nucleus Genomics

Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.

Newswise: Rare but not forgotten
Released: 28-Feb-2024 11:05 PM EST
Rare but not forgotten
University of Utah Health

Finding treatments for children with rare diseases has been a significant hurdle in the medical world. An unexpected source, the common fruit fly, is turning up answers.

Released: 27-Feb-2024 12:05 PM EST
Remote online genetic education programs can spur testing for inherited susceptibility to cancer, study suggests
Dana-Farber Cancer Institute

In the GENERATE study, 90% of those who viewed an online genetic education program chose to be tested for inherited predisposition to pancreatic cancer.

Newswise: A Newborn Genetic Screening Study Reaches New Milestone
Released: 26-Feb-2024 10:05 AM EST
A Newborn Genetic Screening Study Reaches New Milestone
University of North Carolina School of Medicine

A research study named Early Check has screened 1,000 newborns after birth in an effort to help identify rare conditions early, provide treatment, give parents educational information, and connect families with specialists throughout the state of North Carolina.

Released: 26-Feb-2024 9:00 AM EST
Dana-Farber and Gustave Roussy to hold third Transatlantic Exchange: Annual scientific conference dedicated to advancing Oncology research and practice
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the third Transatlantic Exchange in Oncology Conference will address: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine.The meeting, supported by L’Institut Servier, will be held in-person (witha virtual attendance option) on April 12, 2024, at the Revere Hotel Boston Common and livestreamed virtually on Medscape’s platform.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Newswise: VUMC part of major step to achieving precision medicine
Released: 19-Feb-2024 12:05 PM EST
VUMC part of major step to achieving precision medicine
Vanderbilt University Medical Center

An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences. The data, reported Feb. 19 in the journal , constitutes a research resource that is unprecedented in its scale and diversity, as 77% of the participants historically have been underrepresented in biomedical research, and 46% are from underrepresented racial and ethnic minorities.

Released: 13-Feb-2024 11:05 AM EST
Life doesn't stop at age 65. Get the latest on seniors and healthy aging in the Seniors channel
Newswise

Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Released: 4-Jan-2024 4:05 PM EST
Treating tuberculosis when antibiotics no longer work
University of Cologne

In cooperation with research partners in Germany and France, the infectious disease specialist Dr Jan Rybniker and his team at University Hospital Cologne and the University of Cologne’s Faculty of Medicine have identified new, antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans.

Released: 4-Jan-2024 4:05 PM EST
A blood test can identify genetic diseases in fetuses
University of Southern Denmark

A research team from Odense University Hospital and the University of Southern Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: Mediterranean diet ‘a straightforward approach’ among many nutritional options for improving the chance of success in IVF
Released: 20-Dec-2023 12:05 PM EST
Mediterranean diet ‘a straightforward approach’ among many nutritional options for improving the chance of success in IVF
Reproductive Biomedicine Online

Adjuvant therapies to help infertile women conceive by IVF - especially those whose treatments have been unsuccessful in the past - are now a common feature both before and during the treatment cycle. Now, a new analysis of the evidence for many nutritional supplements and diets thought to improve outcome in IVF has concluded that adopting a Mediterranean diet during treatment would offer a single ‘straightforward approach’ with good evidence of benefit in contrast to that of a Western diet.

Newswise:Video Embedded live-event-scientists-create-tiny-biological-robot-healers-assembled-from-human-cells
VIDEO
30-Nov-2023 9:45 AM EST
Video and Transcript: Scientists create tiny biological robot "healers" assembled from human cells
Newswise

Scientists have created tiny moving biological robots from human tracheal cells that can encourage the growth of neurons across artificial ‘wounds’ in the lab. Using patients’ own cells could permit growth of Anthrobots that assist healing and regeneration in the future with no need for immune suppression. Lead researchers Prof Michael Levin and Gizem Gumuskaya from Tufts University will provide a brief commentary on the science and potential impact of this discovery, followed by Q&A with reporters.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Mount Sinai Researchers Find More Than 4,700 Gene Clusters Crucial for Prognosis in 32 Cancer Types
Released: 13-Nov-2023 2:05 PM EST
Mount Sinai Researchers Find More Than 4,700 Gene Clusters Crucial for Prognosis in 32 Cancer Types
Mount Sinai Health System

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed “prognostic modules,” that significantly influence the progression of 32 different types of cancer. The study, published in Genome Research, serves as a comprehensive resource and lays the foundation for the development of next-generation cancer treatments and diagnostic markers.

Newswise: The Medical Minute: Need health care help and don’t speak the language? You’re covered.
Released: 2-Nov-2023 1:05 PM EDT
The Medical Minute: Need health care help and don’t speak the language? You’re covered.
Penn State Health

Ayuda. Aide. Ajuda. Herupu. Maddata. Help. No matter how you ask for it, health care professionals want to make sure language doesn’t get in the way. A Penn State Health expert discusses how medical interpreters can help.

Newswise: Cancer drug shows promise targeting genetic weakness in some tumors, comments Virginia Tech expert
31-Oct-2023 12:00 AM EDT
Cancer drug shows promise targeting genetic weakness in some tumors, comments Virginia Tech expert
Virginia Tech

In an invited commentary, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the potential of a new drug that has shown early promise in clinical trials for solid tumors by killing cancer cells that lack specific tumor suppressor genes.

Released: 30-Oct-2023 3:05 PM EDT
Can personalized care prevent over screening for colorectal cancer in older adults?
Michigan Medicine - University of Michigan

Study reveals presenting adults between 76 and 85 with personalized information about the benefits and harms of colon cancer screening decreases excess screening

Not for public release

This news release is embargoed until 16-Oct-2023 5:00 PM EDT Released to reporters: 10-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 16-Oct-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Case Western Reserve Researcher Leads Project to Expand, Accelerate Personalized Medicine with $3.2M NIH Grant
Released: 11-Oct-2023 9:05 AM EDT
Case Western Reserve Researcher Leads Project to Expand, Accelerate Personalized Medicine with $3.2M NIH Grant
Case Western Reserve University

With a new five-year, $3.2 million grant from the National Institutes of Health (NIH), a Case Western Reserve University researcher is leading a project to expand and accelerate the evolution of personalized medicine in treating diseases.

Newswise: Capturing Immunotherapy Response in a Blood Drop
4-Oct-2023 11:00 AM EDT
Capturing Immunotherapy Response in a Blood Drop
Johns Hopkins Medicine

Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells). When used in patients with advanced non-small cell lung cancer undergoing immunotherapy, they may identify patients who could benefit from treatment with additional drugs, according to a phase 2 clinical trial in the U.S. and Canada. The trial is led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy, BC Cancer and the Canadian Cancer trials Group (CCTG).

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Newswise: Regenerative Medicine: How Scientists Manufacture Cells
Released: 19-Sep-2023 11:05 AM EDT
Regenerative Medicine: How Scientists Manufacture Cells
Cedars-Sinai

In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like these embryonic stem cells.

Newswise: Marcus Autism Center Launches First-Of-Its-Kind FDA-Authorized Device for Early Diagnosis of Autism Spectrum Disorder
Released: 5-Sep-2023 11:00 AM EDT
Marcus Autism Center Launches First-Of-Its-Kind FDA-Authorized Device for Early Diagnosis of Autism Spectrum Disorder
Children's Healthcare of Atlanta

Marcus Autism Center, a subsidiary of Children’s Healthcare of Atlanta, has developed the first biomarker-based, eye-tracking diagnostic technology now available to help diagnose autism.

Released: 31-Aug-2023 9:55 AM EDT
Gene therapy for brain tumor shows promising early results in humans
Michigan Medicine - University of Michigan

A new study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.

29-Aug-2023 5:55 PM EDT
New study shows promising evidence for sickle cell gene therapy
University of Chicago Medical Center

UChicago Medicine Comer Children’s Hospital was one of three sites to enroll patients in a clinical trial to test a potentially curative stem cell gene therapy for sickle cell disease. The results were promising.

Released: 25-Aug-2023 1:05 PM EDT
New gene-editing technique offers path to precision therapies
King Abdullah University of Science & Technology (KAUST)

PNP editing emerges as a versatile and programmable tool for site-specific DNA manipulations.

Released: 23-Aug-2023 6:05 PM EDT
Study from School of Neuroscience urges more research into sex differences in depression
Virginia Tech

In 2016, recognizing that lack of research in female animals was hampering the success of treatments for mood disorders, the National Institutes of Health (NIH) changed its policy for basic research to include sex as a biological variable for basic research, a move that triggered an explosion of research into sex differences.

Released: 22-Aug-2023 9:45 AM EDT
CureMD Announces Strategic Collaboration with Tempus to Integrate Genomic Testing Functionality in EHR
CureMD

CureMD, a leading provider of comprehensive technology solutions for community oncology, is proud to announce its partnership with Tempus, a leader in artificial intelligence and precision medicine, to integrate Tempus' advanced genomic testing capabilities into CureMD's cutting-edge Electronic Health Record (EHR) system.

Newswise: Cleveland Clinic London Patient Receives London’s First Total Knee Replacement Surgery Assisted by Augmented Reality
Released: 17-Aug-2023 11:25 AM EDT
Cleveland Clinic London Patient Receives London’s First Total Knee Replacement Surgery Assisted by Augmented Reality
Cleveland Clinic

Cleveland Clinic London is the first hospital in London to successfully perform a total knee replacement procedure with the assistance of an augmented reality-based surgical platform that was designed with artificial intelligence and machine learning.

Newswise: Fat Burning During Exercise Varies Widely Between Individuals
Released: 10-Aug-2023 4:55 PM EDT
Fat Burning During Exercise Varies Widely Between Individuals
Mount Sinai Health System

The best heart rate for burning fat differs for each individual and often does not align with the “fat burning zone” on commercial exercise machines, Icahn School of Medicine at Mount Sinai researchers report. Instead, the researchers said, clinical exercise testing—a diagnostic procedure to measure a person’s physiological response to exercise—may be a more useful tool to help individuals achieve intended fat loss goals. The study, which used a machine learning-based modeling approach, was published online today in Nutrition, Metabolism and Cardiovascular Disease.

Newswise: New Machine-Learning Method May Aid Personalized Cancer Therapy
Released: 9-Aug-2023 11:00 AM EDT
New Machine-Learning Method May Aid Personalized Cancer Therapy
Johns Hopkins Medicine

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, the technology could help scientists overcome a major hurdle to developing personalized immunotherapies and vaccines.

   
Newswise: Surgeon-Scientist Receives $3.2 Million NIH Grant to Continue Program for Hearing Loss Research
Released: 7-Aug-2023 11:40 AM EDT
Surgeon-Scientist Receives $3.2 Million NIH Grant to Continue Program for Hearing Loss Research
University of Miami Health System, Miller School of Medicine

The University of Miami Miller School of Medicine Department of Otolaryngology has received a new $3.2 million, five-year grant from the National Institutes of Health (NIH) to support their multidisciplinary translational research program on human genetic hearing loss (HL), a common sensory disorder affecting more than 28 million Americans.

Newswise: Researchers Identify Two New Subtypes of HPV-associated Head and Neck Cancers
Released: 31-Jul-2023 4:05 PM EDT
Researchers Identify Two New Subtypes of HPV-associated Head and Neck Cancers
University of North Carolina School of Medicine

Researchers in UNC School of Medicine’s Department of Otolaryngology/Head and Neck Surgery and collaborators at Yale Cancer Center and ECOG-ACRIN Cancer Research Group have identified two subtypes of human papillomavirus positive head and neck cancers, giving them a better glimpse into why some patients respond better to treatment than others.

Released: 27-Jul-2023 2:20 PM EDT
Advances in Big Data for Precision Medicine, Novel Technologies to Determine a Pathogen’s Susceptibility to Antibiotics, the Microbiome’s Impact on Childhood Undernutrition, and More Draw Nearly 20,000 Attendees to 2023 AACC Annual Scientific Meeting
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

The Association for Diagnostics and Laboratory Medicine (ADLM), formerly AACC, welcomed thousands of laboratory experts to the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo from July 23-27. At this year’s special meeting celebrating ADLM’s 75th anniversary, the organization officially rolled out a new name that reflects the association’s role as advocate and champion for a larger community specializing in diagnostics and laboratory medicine, as well as its global reach.

Newswise:Video Embedded 3d-metallic-rib-implants-from-spain-give-teenage-cancer-patient-a-second-chance
VIDEO
Released: 27-Jul-2023 1:05 PM EDT
3D Metallic Rib Implants From Spain Give Teenage Cancer Patient a Second Chance
Michigan Medicine - University of Michigan

Her ribs needed to be removed. Her care team searched far and wide and found the best possible treatment.

Released: 26-Jul-2023 1:10 PM EDT
Revolutionizing Liquid Biopsy: Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
2023 AACC Annual Scientific Meeting Press Program

Zymo Research Corp, a leading provider of life science technologies, has partnered with Opentrons Labworks, Inc., a leader in lab automation, to revolutionize cell-free DNA isolation and analysis.

Newswise: AI Empowers Researchers to Bring Precision Medicine to Post-stroke Speech and Cognitive Rehabilitation
Released: 26-Jul-2023 8:00 AM EDT
AI Empowers Researchers to Bring Precision Medicine to Post-stroke Speech and Cognitive Rehabilitation
Constant Therapy Health

Constant Therapy Health, a next generation digital health company, today announced that the organization is empowering Boston University Center for Brain Recovery and The University of Texas at Austin neuroscientists, data engineers and computational scientists with the AI-driven, real-world data needed to bring precision medicine to post-stroke speech, language and cognitive rehabilitation.

19-Jul-2023 10:00 AM EDT
Microbiome-Directed Therapies for Undernutrition, Big Data for Precision Medicine, Health Equity, and More to Be Explored at 2023 AACC Annual Scientific Meeting & Clinical Lab Expo
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory experts will present cutting-edge research and technology that is shaping the future of clinical testing and patient care.

Released: 20-Jul-2023 6:00 PM EDT
Los investigadores de Mayo Clinic preparan el terreno para el tratamiento individualizado de la obesidad, adaptando las intervenciones a las necesidades de cada persona
Mayo Clinic

En un estudio piloto de 165 personas, los investigadores de Mayo Clinic analizaron la eficacia de dos enfoques distintos para la pérdida de peso: una intervención estándar en el estilo de vida y tratamiento individualizado. La intervención estándar en el estilo de vida comprendía una dieta reducida, ejercicio y terapia conductual.

Released: 20-Jul-2023 12:30 PM EDT
Tell us how you really feel -- keep up with the latest research in Psychology and Psychiatry
Newswise

The latest research in psychology and psychiatry on Newswise.

       
Released: 20-Jul-2023 5:00 AM EDT
يُمهد باحثو مايو كلينك الطريق لعلاج السُمنة بصورة فردية، وتخصيص التدخلات وفقًا لاحتياجات الشخص
Mayo Clinic

فيدراسة تجريبية شملت 165 شخصًا، درس باحثو مايو كلينك فعّالية طريقتين مختلفتين لفقدان الوزن: تدخُّل قياسي في نمط الحياة وعلاج فردي.

Released: 20-Jul-2023 5:00 AM EDT
Pesquisadores da Mayo Clinic pavimentam o caminho para a terapia individualizada de obesidade, adaptando as intervenções para as necessidades pessoais
Mayo Clinic

Em um estudo piloto com 165 pessoas, pesquisadores da Mayo Clinic observaram a efetividade em duas abordagens de perda de peso: a intervenção no estilo de vida padrão e a terapia individualizada.

Newswise: Ochsner Health is the First in Louisiana to Offer Aquablation Therapy, the Only Image-Guided, Heat-Free Robotic Therapy to Treat BPH
Released: 19-Jul-2023 10:30 AM EDT
Ochsner Health is the First in Louisiana to Offer Aquablation Therapy, the Only Image-Guided, Heat-Free Robotic Therapy to Treat BPH
Ochsner Health

Ochsner Health announced today that it has become the first healthcare organization in Louisiana to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).

Released: 18-Jul-2023 4:05 PM EDT
UCLA biobank study reveals disease risk, heath care use among LA’s diverse population
University of California, Los Angeles (UCLA), Health Sciences

The research underscores the limitations of the health care system’s frequent reliance on broad self-reported race and ethnicity data to assess patients’ risk of developing disease, and the findings also support expanding genetic screening to more groups.

Released: 14-Jul-2023 1:05 PM EDT
Exercise during dialysis has positive health impact
Technical University of Munich

Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not.

Released: 13-Jul-2023 11:00 AM EDT
Combination Cancer Therapies Can Shrink Tumors and Improve Survival Outcomes for Patients with Advanced Non-Small Cell Lung Cancer
Yale Cancer Center/Smilow Cancer Hospital

While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in the tumor microenvironment.

Newswise: Making Headway in Precision Therapeutics with Novel Fully Organic Bioelectronic Device
Released: 10-Jul-2023 4:05 PM EDT
Making Headway in Precision Therapeutics with Novel Fully Organic Bioelectronic Device
Columbia University School of Engineering and Applied Science

Columbia Engineering researchers announced today that they have developed the first stand-alone, conformable, fully organic bioelectronic device that can not only acquire and transmit neurophysiologic brain signals, but can also provide power for device operation.

   


close
2.15529